Controversies in the treatment of plasma cell myeloma.
D000208:Acute Disease; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001847:Bone Diseases / Q000188:drug therapy / Q000209:etiology; D004351:Drug Resistance; D006801:Humans; D007938:Leukemia / Q000209:etiology; D008558:Melphalan / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D059408:Pain Management; D011241:Prednisone / Q000627:therapeutic use
D008558:Melphalan; D011241:Prednisone